AksharChem (India) Ltd Upgraded to Sell: Technical Improvements Drive Rating Change

Quality Assessment: Weak Fundamentals Persist

AksharChem’s quality metrics continue to reflect significant weaknesses. Over the past five years, the company has experienced a steep decline in operating profits, with a compounded annual growth rate (CAGR) of -51.13%. This erosion in profitability is a critical concern for investors seeking sustainable earnings growth. The company’s ability to service debt remains fragile, evidenced by an average EBIT to interest coverage ratio of just 1.69, signalling limited buffer to meet interest obligations comfortably.

Return on equity (ROE) further underscores the low profitability per unit of shareholder funds, averaging a mere 2.40%. This figure is well below industry standards and highlights the company’s struggle to generate adequate returns for its equity holders. The recent quarterly results for Q4 FY25-26 were flat, with profit before tax excluding other income (PBT LESS OI) falling by 11.6% to a loss of ₹1.08 crore. Interest expenses reached a quarterly high of ₹2.15 crore, exacerbating financial strain.

Valuation: Attractive but Reflective of Risks

Despite the weak fundamentals, AksharChem’s valuation metrics present a more favourable picture. The company’s return on capital employed (ROCE) stands at 3.3%, which, while modest, is supported by an attractive enterprise value to capital employed ratio of 0.8. This suggests the stock is trading at a discount relative to its peers’ historical valuations, potentially offering value for investors willing to accept the associated risks.

However, this valuation attractiveness is tempered by the company’s poor profit trajectory. Over the past year, profits have plummeted by 144.9%, even as the stock price has managed a modest 4.89% return. This divergence indicates that the market may be pricing in some recovery or technical momentum rather than fundamental strength.

Financial Trend: Flat Performance Amidst Declining Profitability

The company’s recent financial trend remains largely flat, with Q4 FY25-26 results showing no significant improvement. The loss before tax excluding other income of ₹1.08 crore marks a deterioration compared to the previous four-quarter average. Interest costs have risen to their highest quarterly level, further pressuring earnings.

Long-term financial trends are unfavourable, with operating profits declining sharply over five years. The company’s inability to generate consistent profit growth and manage debt effectively has kept its financial trend rating subdued. This weak financial trajectory contrasts with the modest stock price appreciation observed over the past year and year-to-date periods.

Technical Analysis: Key Driver of Rating Upgrade

The primary catalyst for the upgrade from Strong Sell to Sell is the improvement in technical indicators. The technical trend has shifted from mildly bearish to sideways, signalling a stabilisation in price movement. Key technical metrics present a mixed but cautiously optimistic picture:

• MACD on a weekly basis is mildly bullish, although monthly readings remain bearish.
• Relative Strength Index (RSI) shows no clear signal on both weekly and monthly charts, indicating a neutral momentum.
• Bollinger Bands are bullish on both weekly and monthly timeframes, suggesting potential upward price volatility.
• Moving averages on a daily basis remain mildly bearish, reflecting some short-term caution.
• KST indicator is mildly bullish weekly but bearish monthly, highlighting mixed momentum signals.
• Dow Theory readings are mildly bullish on both weekly and monthly charts, supporting a tentative positive outlook.
• On-balance volume (OBV) is mildly bullish weekly and bullish monthly, indicating accumulation by investors.

These technical signals collectively suggest that while the stock is not yet in a strong uptrend, the downward pressure has eased, and sideways consolidation may provide a base for future gains. This technical stabilisation has been reflected in the stock’s recent price action, with a day change of +13.09% and a current price of ₹249.70, up from the previous close of ₹220.80.

Stock Performance Relative to Sensex

AksharChem’s stock has outperformed the Sensex over short-term periods, with a 1-week return of 20.37% compared to Sensex’s 1.69%, and a 1-month return of 23.46% versus Sensex’s 2.13%. Year-to-date, the stock has gained 5.89%, while the Sensex has declined by 9.88%. Over one year, the stock returned 4.89% against the Sensex’s -5.60%. However, longer-term returns lag significantly, with a 5-year return of -30.59% compared to Sensex’s 46.73%, reflecting the company’s fundamental challenges.

Ownership and Market Capitalisation

AksharChem remains a micro-cap stock with majority ownership held by promoters. This concentrated ownership structure can influence strategic decisions and market liquidity. Investors should consider the implications of promoter control alongside the company’s financial and technical profile.

Conclusion: A Cautious Upgrade Reflecting Technical Stabilisation

The upgrade of AksharChem (India) Ltd’s rating from Strong Sell to Sell by MarketsMOJO reflects a cautious optimism driven by improved technical indicators amid persistent fundamental weaknesses. While the company’s financial performance remains flat with declining profitability and weak debt servicing capacity, the stock’s valuation is attractive relative to peers, and technical signals suggest a potential bottoming out of price declines.

Investors should weigh the risks of the company’s weak long-term fundamentals against the possibility of a technical rebound. The sideways technical trend and bullish signals on Bollinger Bands and OBV provide some support for the stock, but the absence of strong financial momentum and low profitability metrics warrant a conservative stance. As such, the Sell rating indicates that while the stock is no longer a strong sell, it remains a cautious investment requiring close monitoring of both financial results and market technicals.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →